Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Outstanding
Ratios

Alaunos Therapeutics (TCRT) Shares Issued (2016 - 2023)

Historic Shares Issued for Alaunos Therapeutics (TCRT) over the last 12 years, with Q1 2023 value amounting to $92000.0.

  • Alaunos Therapeutics' Shares Issued changed N/A to $92000.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $92000.0, marking a year-over-year decrease of 9937.52%. This contributed to the annual value of $92000.0 for FY2023, which is 9937.52% down from last year.
  • Alaunos Therapeutics' Shares Issued amounted to $92000.0 in Q1 2023.
  • Over the past 5 years, Alaunos Therapeutics' Shares Issued peaked at $100.0 million during Q2 2019, and registered a low of -$1000.0 during Q4 2021.
  • Moreover, its 5-year median value for Shares Issued was $92000.0 (2023), whereas its average is $22.7 million.
  • As far as peak fluctuations go, Alaunos Therapeutics' Shares Issued tumbled by 9885.29% in 2021, and later soared by 147040000.0% in 2022.
  • Alaunos Therapeutics' Shares Issued (Quarter) stood at $100.0 million in 2019, then fell by 11.34% to $88.7 million in 2020, then tumbled by 100.0% to -$1000.0 in 2021, then skyrocketed by 1470400.0% to $14.7 million in 2022, then tumbled by 99.37% to $92000.0 in 2023.
  • Its Shares Issued stands at $92000.0 for Q1 2023, versus $14.7 million for Q4 2022 and $21000.0 for Q3 2022.